Antitumor progestins activity: Cytostatic effect and immune response
Authors:
Abstract
No abstract availableKeywords
Funding Information
- RUDN University (025323-2-000)
This publication has 160 references indexed in Scilit:
- The role of non‐genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell deathCancer Reports, 2023
- Prospective study of fertility‐sparing treatment with chlormadinone acetate for endometrial carcinoma and atypical hyperplasia in young womenInternational Journal of Gynecology & Obstetrics, 2021
- Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunityCancer Medicine, 2020
- Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA‐146b‐5p mediated Wnt/β‐catenin signalingIUBMB Life, 2018
- Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functionsCancer Immunology, Immunotherapy, 2013
- Endometrial cancer invasion depends on cancer‐derived tumor necrosis factor‐α and stromal derived hepatocyte growth factorInternational Journal of Cancer, 2009
- Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestinsCancer, 1997
- NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: Hormone regulatory effects in vivoThe Prostate, 1992
- The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancerCancer, 1991
- Gestagens in the management of prostatic carcinomaInternational Urology and Nephrology, 1984